Review Article
Potential Role of Antioxidants as Adjunctive Therapy in Chagas Disease
Table 3
Summarized presentation of oxidative stress markers and effects of antioxidant supplements evaluated in T. cruzi infection and Chagas disease.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
+: studies show statistically significant changes of diminishing oxidative stress markers; X: studies show statistically significant detrimental results in oxidative stress markers; =: no changes in measurements in oxidative stress markers; I or D: studies show increase or decrease in antioxidant enzyme levels after antioxidant exposure, respectively; Α: animal models; H: human patients; NO: nitric oxide; PCN: protein carbonylation; glutathione: GSH, GPx, or GST; SOD: superoxide dismutase; CAT: catalase. PBN: phenyl-alfa-tert-butyl nitrone. |